Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Palliative urinary diversion for pelvic malignancy.

E N Brin, M Schiff, R M Weiss

    The Journal of Urology
    |May 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Long-Term Follow-Up of Patients With Transaldolase Deficiency.

    Journal of inherited metabolic disease·2026
    Same author

    Seizures and electroencephalographic findings in inborn errors of metabolism: Clues to differential diagnosis in the neonatal period, infancy, childhood and adolescence, and review of the literature.

    Epileptic disorders : international epilepsy journal with videotape·2025
    Same author

    Enlargement of the Optic Chiasm: A Novel Imaging Finding in Glutaric Aciduria Type 1.

    AJNR. American journal of neuroradiology·2021
    Same author

    Sensory neuronopathy as a major clinical feature of mitochondrial trifunctional protein deficiency in adults.

    Revue neurologique·2020
    Same author

    Transition from pediatric to adult care in adolescents with hereditary metabolic diseases: Specific guidelines from the French network for rare inherited metabolic diseases (G2M).

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2018
    Same author

    [Neonatal weight loss with neurological degeneration].

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2016
    Same journal

    On the Memoryless Property in Markov Models for NMIBC Cost-Effectiveness Analysis.

    The Journal of urology·2026
    Same journal

    Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.

    The Journal of urology·2026
    Same journal

    Urinary Supersaturation in a Randomized Trial among Individuals with Recurrent Nephrolithiasis comparing Empiric versus Selective Preventive Therapy: The URINE Trial.

    The Journal of urology·2026
    Same journal

    The FDA Should Allow More BCG Strains into the US Market: How Recent Landmark Trials Expose a Regulatory Paradox.

    The Journal of urology·2026
    Same journal

    Let's Shift the Focus from Death to Life after Fournier's Gangrene.

    The Journal of urology·2026
    Same journal

    Endourology and Nephrolithiasis.

    The Journal of urology·2026
    See all related articles

    Palliative urinary diversion offers limited survival benefits for advanced pelvic cancers, with most post-procedure time spent hospitalized. Prostate cancer patients showed slightly better outcomes compared to other pelvic malignancies.

    Area of Science:

    • Urology
    • Oncology
    • Palliative Care

    Background:

    • Advanced pelvic malignancies frequently cause ureteral obstruction.
    • Urinary diversion is a palliative measure for such cases.
    • Limited data exists on survival outcomes and quality of life post-diversion.

    Purpose of the Study:

    • To evaluate the efficacy of palliative urinary diversion in patients with ureteral obstruction due to advanced pelvic malignancy.
    • To assess survival time and hospitalization duration following urinary diversion.
    • To compare outcomes based on the primary tumor site.

    Main Methods:

    • Retrospective analysis of 47 patients undergoing palliative urinary diversion for ureteral obstruction.
    • Data collection on survival time, time to death, and hospitalization duration.

    Related Experiment Videos

  • Stratification of results by primary cancer type.

    • Main Results:

    • Average survival was 5.3 months; 50% survival at 3 months, 22.7% at 6 months.
    • 63.8% of survival time was spent in the hospital post-diversion.
    • Patients with prostate carcinoma demonstrated improved survival compared to other pelvic tumor origins.

    Conclusions:

    • Palliative urinary diversion provides short-term palliation but limited survival benefit in advanced pelvic malignancy.
    • Hospitalization burden is substantial after diversion.
    • The natural history of prostate cancer may influence better outcomes in this subgroup.